Alkermes PlcNASDAQ:ALKS
- LAST PRICE30.1118
- TODAY'S CHANGE (%)1.2518 (4.3375%)
- Bid / Lots30.1000/ 8
- Ask / Lots30.1200/ 10
- Open / Previous Close29.1200 / 28.8600
- Day Range
- 52 Week Range
- Volume762,163
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALKS |
|---|---|---|
| 09:32 ET | 14950 | 29.03 |
| 09:33 ET | 650 | 29.11 |
| 09:35 ET | 7754 | 29.27 |
| 09:37 ET | 2600 | 29.275 |
| 09:39 ET | 4748 | 29.275 |
| 09:42 ET | 1900 | 29.385 |
| 09:44 ET | 10100 | 29.4 |
| 09:46 ET | 3738 | 29.58 |
| 09:48 ET | 1200 | 29.6 |
| 09:50 ET | 3306 | 29.64 |
| 09:51 ET | 2338 | 29.67 |
| 09:53 ET | 3149 | 29.665 |
| 09:55 ET | 1680 | 29.62 |
| 09:57 ET | 966 | 29.72 |
| 10:00 ET | 1458 | 29.73 |
| 10:02 ET | 1482 | 29.73 |
| 10:04 ET | 400 | 29.71 |
| 10:06 ET | 400 | 29.78 |
| 10:08 ET | 1058 | 29.73 |
| 10:09 ET | 2606 | 29.79 |
| 10:11 ET | 3200 | 29.7137 |
| 10:13 ET | 1252 | 29.78 |
| 10:15 ET | 300 | 29.78 |
| 10:18 ET | 3376 | 29.81 |
| 10:20 ET | 500 | 29.81 |
| 10:22 ET | 900 | 29.8 |
| 10:24 ET | 1127 | 29.835 |
| 10:26 ET | 5839 | 29.825 |
| 10:27 ET | 1300 | 29.83 |
| 10:29 ET | 1610 | 29.86 |
| 10:31 ET | 2792 | 29.81 |
| 10:33 ET | 1260 | 29.815 |
| 10:36 ET | 5504 | 29.825 |
| 10:38 ET | 5895 | 29.82 |
| 10:40 ET | 7504 | 29.76 |
| 10:42 ET | 2450 | 29.74 |
| 10:44 ET | 17300 | 29.71 |
| 10:45 ET | 700 | 29.69 |
| 10:47 ET | 1354 | 29.74 |
| 10:49 ET | 600 | 29.755 |
| 10:51 ET | 600 | 29.78 |
| 10:54 ET | 200 | 29.77 |
| 10:56 ET | 2765 | 29.74 |
| 10:58 ET | 900 | 29.735 |
| 11:00 ET | 765 | 29.755 |
| 11:02 ET | 651 | 29.77 |
| 11:03 ET | 677 | 29.77 |
| 11:05 ET | 1400 | 29.79 |
| 11:07 ET | 1649 | 29.85 |
| 11:09 ET | 30334 | 29.91 |
| 11:12 ET | 1300 | 29.9 |
| 11:14 ET | 710 | 29.82 |
| 11:16 ET | 1625 | 29.8 |
| 11:18 ET | 600 | 29.8 |
| 11:20 ET | 7850 | 29.94 |
| 11:21 ET | 3505 | 29.92 |
| 11:23 ET | 3300 | 29.96 |
| 11:25 ET | 500 | 29.974103 |
| 11:27 ET | 2049 | 29.96 |
| 11:30 ET | 3858 | 29.98 |
| 11:32 ET | 1220 | 29.93 |
| 11:34 ET | 720 | 29.96 |
| 11:36 ET | 47477 | 29.97 |
| 11:38 ET | 13321 | 29.975 |
| 11:39 ET | 10120 | 29.975 |
| 11:41 ET | 2604 | 29.94 |
| 11:43 ET | 5158 | 29.805 |
| 11:45 ET | 1965 | 29.85 |
| 11:48 ET | 1015 | 29.855 |
| 11:50 ET | 400 | 29.855 |
| 11:52 ET | 400 | 29.86 |
| 11:54 ET | 725 | 29.86 |
| 11:56 ET | 2057 | 29.9 |
| 11:57 ET | 414 | 29.8991 |
| 11:59 ET | 2181 | 29.94 |
| 12:01 ET | 1915 | 29.965 |
| 12:03 ET | 12870 | 29.945 |
| 12:06 ET | 692 | 29.955 |
| 12:08 ET | 2063 | 29.93 |
| 12:10 ET | 7898 | 29.84 |
| 12:14 ET | 1000 | 29.87 |
| 12:17 ET | 2169 | 29.85 |
| 12:19 ET | 600 | 29.835 |
| 12:21 ET | 6203 | 29.75 |
| 12:24 ET | 694 | 29.77 |
| 12:26 ET | 803 | 29.7799 |
| 12:28 ET | 100 | 29.765 |
| 12:30 ET | 300 | 29.77 |
| 12:32 ET | 1627 | 29.815 |
| 12:35 ET | 1334 | 29.87 |
| 12:39 ET | 5854 | 29.92 |
| 12:42 ET | 3442 | 29.95 |
| 12:44 ET | 4527 | 29.91 |
| 12:46 ET | 2217 | 29.9 |
| 12:48 ET | 1384 | 29.91 |
| 12:50 ET | 1472 | 29.9117 |
| 12:51 ET | 5027 | 29.9 |
| 12:53 ET | 1028 | 29.95 |
| 12:55 ET | 1167 | 29.98 |
| 12:57 ET | 1155 | 29.97 |
| 01:00 ET | 2066 | 29.97 |
| 01:02 ET | 1700 | 29.96 |
| 01:04 ET | 2516 | 29.94 |
| 01:06 ET | 1096 | 29.95 |
| 01:08 ET | 1824 | 29.93 |
| 01:09 ET | 4995 | 29.935 |
| 01:11 ET | 1343 | 29.94 |
| 01:13 ET | 600 | 29.92 |
| 01:15 ET | 1013 | 29.93 |
| 01:18 ET | 1600 | 29.94 |
| 01:20 ET | 1466 | 29.92 |
| 01:22 ET | 2131 | 29.91 |
| 01:24 ET | 1320 | 29.9 |
| 01:26 ET | 1918 | 29.92 |
| 01:27 ET | 936 | 29.92 |
| 01:29 ET | 2100 | 29.92 |
| 01:31 ET | 4488 | 29.98 |
| 01:33 ET | 1162 | 29.99 |
| 01:36 ET | 11242 | 30.005 |
| 01:38 ET | 11181 | 30.03 |
| 01:40 ET | 3074 | 30.015 |
| 01:42 ET | 4701 | 30.01 |
| 01:44 ET | 2453 | 29.985 |
| 01:45 ET | 1534 | 29.985 |
| 01:47 ET | 2812 | 30.005 |
| 01:49 ET | 2329 | 29.995 |
| 01:51 ET | 500 | 29.985 |
| 01:54 ET | 3621 | 30.005 |
| 01:56 ET | 600 | 30.01 |
| 01:58 ET | 3367 | 30.015 |
| 02:00 ET | 2384 | 30.015 |
| 02:02 ET | 1705 | 30.015 |
| 02:03 ET | 26356 | 30.08 |
| 02:05 ET | 1700 | 30.075 |
| 02:07 ET | 800 | 30.075 |
| 02:09 ET | 3548 | 30.13 |
| 02:12 ET | 2245 | 30.12 |
| 02:14 ET | 3038 | 30.1118 |
Nov 7, 2024
Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
DJ Alkermes Raised to Buy From Hold by Stifel, from 6:11AM ET on Tuesday Nov 05, 2024 by Dow Jones
6:11AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 25, 2024
DJ Alkermes Is Maintained at Buy by Goldman Sachs, from 1:50PM ET on Friday Oct 25, 2024 by Dow Jones
1:50PM ET on Friday Oct 25, 2024 by Dow JonesDJ Alkermes Is Maintained at Overweight by Cantor Fitzgerald, from 12:09PM ET on Friday Oct 25, 2024 by Dow Jones
12:09PM ET on Friday Oct 25, 2024 by Dow JonesDJ Alkermes Is Maintained at Neutral by JP Morgan, from 11:49AM ET on Friday Oct 25, 2024 by Dow Jones
11:49AM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alkermes Plc | 4.7B | 10.2x | --- |
Exelixis Inc | 10.4B | 23.1x | -21.77% |
Qiagen NV | 9.8B | 138.2x | +12.66% |
P3 Health Partners Inc | 134.0M | -0.7x | --- |
Ionis Pharmaceuticals Inc | 6.2B | -16.0x | --- |
Novavax Inc | 1.4B | -3.3x | --- |
Company Information
Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Contact Information
- Headquarters
- Connaught House 1 Burlington Road, Dublin 4DUBLIN, Ireland D04 C5Y6
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Richard Pops
- Interim Chief Financial Officer, Chief Operating Officer, Executive Vice President, Interim Chief Accounting Officer
- Blair Jackson
- Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary
- David Gaffin
- Executive Vice President, Research and Development and Chief Medical Officer
- Craig Hopkinson
- Senior Vice President, Chief Commercial Officer
- C.Todd Nichols
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
|---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 161.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $2.95 |
Book Value | $7.20 |
P/E Ratio | 10.2x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 8.6x |
Operating Margin | 29.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
